Brightpoint Health eHIVQual 2017 Cascades.

Slides:



Advertisements
Similar presentations
MINNESOTAS HIV TREATMENT CASCADE. Introduction This slide set describes the continuum of HIV care in Minnesota. The slides rely on data from HIV/AIDS.
Advertisements

Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
HIV Prevention Georgia Test, Link, and Care (TLC) Network
HIV Care Continuum for the United States and Puerto Rico National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
Harlem ID Clinic QI Viral Load Suppression Harlem Hospital Center Michael Serlin, MD Medical Director, Harlem Family Center October 9, 2013.
Illustrating the HIV Care Continuum in U.S. Cities Chicago, IL.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
Positive Living Navajo AIDS Network, Inc. Melvin Harrison, Executive Director Marco Arviso, Arizona Medical Case Manager.
Using surveillance data to initiate public health outreach to persons out of care and assist with re-engagement with care and partner services Chi-Chi.
Cascade of HIV Care in the Netherlands from 2002 to Esther Engelhard 14th European AIDS Conference October 18, 2013 Disclosed no conflict of interest.
Introduction DCDOH supports HIV test and treat activities - increased number of HIV tests performed, emphasis on earlier linkage to care. Limited data.
Quality Management Chart Review Pamela Casey, MS, RD June 24, 2014.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
HIV Care Continuum, District 8- 2 Southwest (Albany), Georgia, 2012.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Positive Living Navajo AIDS Network, Inc. Melvin Harrison, Executive Director Marco Arviso, Arizona Medical Case Manager.
HIV Care Continuum, Georgia, United States, 2011 Presented to American Public Health Association, Annual Meeting Presented by Deepali Rane, MBBS, MPH,
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.
HIV Care Continuum, District 10 Northeast (Athens), Georgia, 2012.
Monitoring Indicators of the National HIV/AIDS Strategy Using Data for Public Health Action Irene Hall, PhD, FACE HIV Incidence and Case Surveillance Branch.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The United Kingdom provides excellent access and quality of.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
1 Understanding and Using Your HIVQUAL Data March, 2011 HIVQUAL Workshop.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
The Continuum of HIV Care Florida, 2014 The Continuum of HIV Care Florida, 2014 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2014, as of.
MINNESOTA’S HIV TREATMENT CASCADE April, Introduction.
1 Adherence to ARV Therapy and Resistance HAIVN Havard Medical School AIDS Initiative in Vietnam.
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
Figure 2: Trends in currently prescribed antiretroviral therapy % prescribed HAART increased from 74% to 83% Trends in ART use, HIV viral load, and CD4.
Innovations in Primary Care: Implementing Clinical Care Management in Primary Care Practices Judith Steinberg, MD, MPH Deputy Chief Medical Officer Jeanne.
Summary of HIV Infection in Alaska, 1982–2015 Prepared by the State of Alaska Department of Health and Social Services, Division of Public Health, HIV/STD.
POSITIVELY CONNECTED FOR HEALTH (PC4H) Helen Koenig, MD Juliet Fink Yates, Ed.M Nadia Dowshen, MD Susan Lee, MPH Philadelphia, PA.
Improving health worldwide Implications for Monitoring of the HIV Care Cascade? Jim Todd MeSH Satellite Session IAS Durban, Monday 18 th.
Priscilla Tsondai, Lynne Wilkinson, Anna Grimsrud, Angelina Trivino,
End the Epidemic Quality Improvement Project 2016.
New WHO Guidelines on Person centred monitoring
HIV Care Continuum Ryan White Program - Miami-Dade County
Differentiated Monitoring & Evaluation
Illustrating the HIV Care Continuum in U.S. Cities
Continuum of Surveillance Updates from Epidemiological Services New Jersey Department of Health Division of HIV, STD and TB Services (DHSTS) Annual.
eHIVQUAL 2016 Overview February 15, 2017
Illustrating the HIV Care Continuum in U.S. Cities
Melanie L. Fritza Ronald J. Lubelchek, MD a, b, c*
Establishing the H4C Viral Suppression Cohort
Statewide Health Information Network of New York (SHIN-NY) and Regional Health Information Organizations (RHIOs) Institute for Implementation Science in.
NYSDOH AIDS Institute Quality of Care Program eHIVQUAL
HIV Care Continuum in Manhattan
Illustrating the HIV Care Continuum in U.S. Cities
Howard Brown Health, Chicago
Chloe Orkin British HIV Association Queen Mary University London
Illustrating the HIV Care Continuum in U.S. Cities
HIV Quality Improvement (QI) and the Treatment Cascade: How QI has Impacted Reach, Recruitment, Testing, Treatment, and Retention Efforts in Thailand?
Dr. Velephi Okello, Principal Investigator, MaxART Trial
2017 HIV Care Cascade Submission
Care Cascade 2017 Jameela Yusuff MD MPH FACP
Our Strategies for Viral Load Suppression
Poster WP41; Contact: David A. Katz,
Illustrating the HIV Care Continuum in U.S. Cities
Needs Assessment Slides for Module 4
PARK WEST HEALTH SYSTEM, INC.
HIV.
Brooklyn Regional Group
Performing Sedia Asante: Testing algorithm
Performing Maxim Swift RIA: Testing algorithm
In+care 04: Viral Load Suppression Factors Influencing Data
U=U Guidance for Implementation in Clinical Settings
HIV Recency Testing in Rwanda
Undetectable = Untransmittable
Best Practices in Building HIV Care Networks
Presentation transcript:

Brightpoint Health eHIVQual 2017 Cascades

Methodology Brightpoint Health ▌ eHIVQual ▌ 2017

Newly diagnosed/new-to-care caseload The number of patients newly diagnosed at the organization in 2017 was determined: Newly diagnosed HIV patients were reported with DOH, and this helped us tally our total newly diagnosed HIV patient count. The number of patients newly diagnosed outside the organization in 2017 was determined: We are unable to determine this cohort as we do not consistently document the initial HIV diagnosis date or HIV determined by which practice in our ancillary EMRs such as Treat (for ADHC patients ) and RMA (for Health Home patients. The number of previously diagnosed new-to-care was determined: EMR (Ecw) documents the initial HIV diagnosis date. This initial HIV dx date along with the information from the EMR when these patients started receiving primary care at our organization with a HIV provider team helped determine these previously diagnosed new-to-care HIV patients at the organization. Brightpoint Health ▌ eHIVQual ▌ 2017

Previously diagnosed caseload The number of patients diagnosed patients who received any service at the organization was determined: From the EMR (Ecw) and Data Warehouse we were able to determine all HIV patients that were served by our organization in any service line (Primary Care, OB/GYN, Pediatrics, Podiatry, Dental, Health Home, ADHC, Mental Health/A31, Mobile Clinics, ADHC, Health Home and more ) by any clinical/non-clinical provider in the year 2017. Explain the methodology used to identify, determine and confirm the care status of open patients: HIV patients from ADHC & Health Home identified from the Data Warehouse were matched with HIV patients from Ecw using Medicaid IDs to prevent duplication. The unique count of HIV patients from both sources Data Warehouse and Ecw were identified as open patients. Explain how patients were determined to be deceased, incarcerated or in care at an outside organization: While Ecw does have fields to document this information it is not necessarily documented. So, we used Nurse Tel encounters made to patients containing keywords related to deceased or incarcerated and then manually reviewed all these patients. For in care outside we used provider documentation in the Progress notes- HIV Treatment section that indicated patient is in care elsewhere or with a specialist for HIV. Brightpoint Health ▌ eHIVQual ▌ 2017

Previously diagnosed caseload (cont’d) The methodology used to identify and confirm the care status of active patients: Established HIV patients who were served by our HIV provider team in 2017 were identified as active patients. These would also be patients with a who are engaged in our primary care services. HIV Provider is a provider who prescribes ARVs and monitors HIV treatment. The service delivery point was determined and verified for non- active patients: Using the visit types in our EMR (Ecw) and source of data ADHC/Health Home from the Data Warehouse we were able to determine the service lines for the non-active patients. Age, gender, race/ethnicity, risk category and housing status was determined and verified for active patients: This information is documented in the demo/profile section in our EMR (Ecw). Brightpoint Health ▌ eHIVQual ▌ 2017

Results Brightpoint Health ▌ eHIVQual ▌ 2017

Newly diagnosed/ new-to-care: # of pts newly diagnosed with HIV in 2017 and all patients new to care in the HIV program in 2017, regardless of HIV diagnosed date Prescribed ART*: Percentage of newly diagnosed and new-to-care pts prescribed ART in 2017 Received Viral Load Test*: Percentage of newly diagnosed and new-to-care pts with a documented viral load test in 2017 Virally Suppressed*: Percentage of newly diagnosed and new-to-care with viral load <200 copies/mL Data Source: eCW NOTE: Only 2 newly diagnosed patients, thus difficult to read colors on the graph Brightpoint Health ▌ eHIVQual ▌ 2017

Active: Percentage of open patients with HIV visit in 2017 Open: # PLWH, diagnosed before measurement year, with any visit in 2017, except those confirmed to be in care elsewhere (858), deceased (7), and incarcerated (7) Active: Percentage of open patients with HIV visit in 2017 Prescribed ART: Percentage of open patients prescribed an ART in 2017 Received Viral Load Test*: Percentage of open pts with a documented viral load test in 2017 Virally Suppressed*: Percentage of open patients with viral load <200 copies/mL Data Source: eCW Brightpoint Health ▌ eHIVQual ▌ 2017

Active: Percentage of patients (excluding new/ newly diagnosed) who received primary care services at the organization in 2017 Prescribed ART: Percentage of active patients prescribed an ART in 2017 Received Viral Load Test*: Percentage of active pts with a documented viral load test in 2017 Virally Suppressed*: Percentage of newly diagnosed and new-to-care with viral load <200 copies/mL Data Source: eCW Brightpoint Health ▌ eHIVQual ▌ 2017

Active: Percentage of patients (excluding new/ newly diagnosed) who received primary care services at the organization in 2017 Prescribed ART: Percentage of active patients prescribed an ART in 2017 Received Viral Load Test*: Percentage of active pts with a documented viral load test in 2017 Virally Suppressed*: Percentage of newly diagnosed and new-to-care with viral load <200 copies/mL Data Source: eCW Brightpoint Health ▌ eHIVQual ▌ 2017

Service Delivery Point 2017 HIV Treatment Cascade, Service Delivery Points for Non-Active Patients Service Delivery Point # of non-active patients who received service in 2017 Behavioral Health Svcs 120 Dental Clinics 72 Nursing Svcs 1 Case Mgt Svcs 25 Treat only 47 Brightpoint Health ▌ eHIVQual ▌ 2017

Total on ARVs: Percentage of active pts prescribed an ARV in 2017 Active: Percentage of patients (excluding new/ newly diagnosed) who received primary care services at the organization in 2017 Total on ARVs: Percentage of active pts prescribed an ARV in 2017 Received Viral Load Test*: Percentage of active pts with a documented viral load test in 2017 Virally Suppressed*: Percentage of newly diagnosed and new-to-care with viral load <200 copies/mL Data Source: eCW Brightpoint Health ▌ eHIVQual ▌ 2017

Total on ARVs: Percentage of active pts prescribed an ARV in 2017 Active: Percentage of patients (excluding new/ newly diagnosed) who received primary care services at the organization in 2017 Total on ARVs: Percentage of active pts prescribed an ARV in 2017 Received Viral Load Test*: Percentage of active pts with a documented viral load test in 2017 Virally Suppressed*: Percentage of newly diagnosed and new-to-care with viral load <200 copies/mL Data Source: eCW Brightpoint Health ▌ eHIVQual ▌ 2017

Total on ARVs: Percentage of active pts prescribed an ARV in 2017 Active: Percentage of patients (excluding new/ newly diagnosed) who received primary care services at the organization in 2017 Total on ARVs: Percentage of active pts prescribed an ARV in 2017 Received Viral Load Test*: Percentage of active pts with a documented viral load test in 2017 Virally Suppressed*: Percentage of newly diagnosed and new-to-care with viral load <200 copies/mL Data Source: eCW Brightpoint Health ▌ eHIVQual ▌ 2017

Total on ARVs: Percentage of active pts prescribed an ARV in 2017 Active: Percentage of patients (excluding new/ newly diagnosed) who received primary care services at the organization in 2017 Total on ARVs: Percentage of active pts prescribed an ARV in 2017 Received Viral Load Test*: Percentage of active pts with a documented viral load test in 2017 Virally Suppressed*: Percentage of newly diagnosed and new-to-care with viral load <200 copies/mL Data Source: eCW Brightpoint Health ▌ eHIVQual ▌ 2017

Previously Diagnosed Active Patients Brightpoint Health (Breakdown by Risk) Active: Percentage of patients (excluding new/ newly diagnosed) who received primary care services at the organization in 2017 Total on ARVs: Percentage of active pts prescribed an ARV in 2017 Received Viral Load Test*: Percentage of active pts with a documented viral load test in 2017 Virally Suppressed*: Percentage of newly diagnosed and new-to-care with viral load <200 copies/mL Data Source: eCW Brightpoint Health ▌ eHIVQual ▌ 2017

Improvement Plan Brightpoint Health ▌ eHIVQual ▌ 2017

A list of improvement goals that are specific, measurable, time-bound, and relevant to HIV- positive patients. This list should include descriptions of proposed action steps to achieve these goals, as well as timelines for projected completion of action steps. Established, New to Care, and Newly Diagnosed Patients at Legacy Clinical Sites Within 6 months, by 12/31/18, Brightpoint Health’s clinics will improve viral load suppression rates for HIV+ patients from 67% to 76%. Established, New to Care, and Newly Diagnosed Patients at New Clinical Sites (clinics which began servicing patients in 2016 and 2017) Within 6 months, by 12/31/18, Brightpoint Health’s clinics will improve viral load suppression rates for HIV+ patients by 10% points (from 53% to 63%). Within 12 months by 6/30/18, Brightpoint Health’s clinics will improve viral load suppression rates for HIV+ patients by 20% points (from 53% to 73%). ** For open/ inactive patients, education and resources available to support self management support and ultimately VL suppression will be made available. U=U and Undetectable campaign materials will be provided to facilities/ programs who enroll and engaged our open/ inactive patients. Brightpoint Health ▌ eHIVQual ▌ 2017

A list of improvement goals that are specific, measurable, time-bound, and relevant to HIV-positive patients. This list should include descriptions of proposed action steps to achieve these goals, as well as timelines for projected completion of action steps. Open Patients Within 6 months, by 12/31/18, Brightpoint Health will improve the tracking of open patients’ engagement in care by increasing documentation of care status and referrals to care’ at the Inwood Dental and ADHC programs, with the goal of spreading to other clinics across the system. Brightpoint Health ▌ eHIVQual ▌ 2017

Thank you! Brightpoint Health ▌ eHIVQual ▌ 2017